Skip to main content

Newer Technologies in Ocular Oncology

  • Chapter
  • First Online:
Current Advances in Ophthalmic Technology

Part of the book series: Current Practices in Ophthalmology ((CUPROP))

  • 423 Accesses

Abstract

The emergence of technology has transformed ophthalmic oncology from a surgical specialty to one that involves both medical and radiation oncology. With that transition ocular oncologists began to use chemotherapeutic agents and specialized radiation techniques. The first use of radiation focused on eye and vision-sparing external beam for retinoblastoma and implant “plaque” brachytherapy for uveal melanoma. However, the evolution did not stop there. Laser photocoagulation was found useful in the treatment of radiation vasculopathy, cryotherapy for conjunctival tumors, topical chemotherapy, and more. Herein, we discuss the most recent additions to the armamentarium used by ocular oncologists to save eyes, vision, and life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Askew DA, Mickan SM, Soyer HP, Wilkinson D. Effectiveness of 5-fluorouracil treatment for actinic keratosis–a systematic review of randomized controlled trials. Int J Dermatol. 2009;48(5):453–63.

    Article  CAS  PubMed  Google Scholar 

  2. Couch SM, Custer PL. Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy. Ophthalmic Plast Reconstr Surg. 2012;28(3):181–3.

    Article  PubMed  Google Scholar 

  3. Ross AH, Kennedy CT, Collins C, Harrad RA. The use of imiquimod in the treatment of periocular tumours. Orbit. 2010;29(2):83–7.

    Article  CAS  PubMed  Google Scholar 

  4. Naik MP, Mehta A, Abrol S, Kumar S, Gupta VS. Topical 5% 5-fluorouracil in the treatment of multifocal basal cell carcinoma of the face: a novel chemotherapeutic approach. Orbit. 2016;35(6):352–4.

    Article  PubMed  Google Scholar 

  5. de Macedo EM, Carneiro RC, de Lima PP, Silva BG, Matayoshi S. Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial. BMC Ophthalmol. 2015;15:35.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Shi Y, Jia R, Fan X. Ocular basal cell carcinoma: a brief literature review of clinical diagnosis and treatment. Onco Targets Ther. 2017;10:2483–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Karabulut GO, Kaynak P, Ozturker C, Fazil K, Ocak OB, Taskapılı M. Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area. Indian J Ophthalmol. 2017;65(1):48–51.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Garcia-Martin E, Gil-Arribas LM, Idoipe M, Alfaro J, Pueyo V, Pablo LE, et al. Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma. Br J Ophthalmol. 2011;95(10):1393–6.

    Article  CAS  PubMed  Google Scholar 

  9. Blasi MA, Maceroni M, Sammarco MG, Pagliara MM. Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study. Eur J Ophthalmol. 2018;28(2):204–9.

    Article  PubMed  Google Scholar 

  10. Rudkin AK, Muecke JS. Adjuvant 5-fluorouracil in the treatment of localised ocular surface squamous neoplasia. Br J Ophthalmol. 2011;95(7):947–50.

    Article  PubMed  Google Scholar 

  11. Chaugule SS, Park J, Finger PT. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: is surgery necessary? Indian J Ophthalmol. 2018;66(1):55–60.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Joag MG, Sise A, Murillo JC, Sayed-Ahmed IO, Wong JR, Mercado C, et al. Topical 5-fluorouracil 1% as primary treatment for ocular surface squamous neoplasia. Ophthalmology. 2016;123(7):1442–8.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Parrozzani R, Frizziero L, Trainiti S, Testi I, Miglionico G, Pilotto E, et al. Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study. Br J Ophthalmol. 2017;101(8):1094–9.

    Article  PubMed  Google Scholar 

  14. Frucht-Pery J, Sugar J, Baum J, Sutphin JE, Pe’er J, Savir H, et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Ophthalmology. 1997;104(12):2085–93.

    Article  CAS  PubMed  Google Scholar 

  15. Ballalai PL, Erwenne CM, Martins MC, Lowen MS, Barros JN, et al. Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia. Ophthalmic Plast Reconstr Surg. 2009;25(4):296–9.

    Article  PubMed  Google Scholar 

  16. Gupta A, Muecke J. Treatment of ocular surface squamous neoplasia with Mitomycin C. Br J Ophthalmol. 2010;94(5):555–8.

    Article  CAS  PubMed  Google Scholar 

  17. Finger PT, Milner MS, McCormick SA. Topical chemotherapy for conjunctival melanoma. Br J Ophthalmol. 1993;77(10):751–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Finger PT, Czechonska G, Liorikos S. Topical mitomycin-C chemotherapy for conjunctival melanoma and PAM with atypia. Br J Ophthalmol. 1998;82(5):476–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Kurli M, Finger PT. Topical Mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years’ experience. Graefes Arch Clin Exp Ophthalmol. 2005;243(11):1108–14.

    Article  CAS  PubMed  Google Scholar 

  20. Finger PT, Sedeek RW, Chin KJ. Topical interferon Alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex. Am J Ophthalmol. 2008;145(1):124–9.

    Article  CAS  PubMed  Google Scholar 

  21. Klauber S, Jensen PK, Prause JU, Kessing SV. Surgical treatment of iris and ciliary body melanoma: follow-up of a 25-year series of patients. Acta Ophthalmol. 2012;90(2):122–6.

    Article  PubMed  Google Scholar 

  22. Shields CL, Manquez ME, Ehya H, Mashayekhi A, Danzig CJ, Shields JA. Fine-needle aspiration biopsy of iris tumors in 100 consecutive cases: technique and complications. Ophthalmology. 2006;113(11):2080–6.

    Article  PubMed  Google Scholar 

  23. Finger PT, Latkany P, Kurli M, Iacob C. The finger iridectomy technique: small incision biopsy of anterior segment tumors. Br J Ophthalmol. 2005;89(8):946–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Petousis V, Finger PT, Milman T. Anterior segment tumor biopsy using an aspiration cutter technique: clinical experience. Am J Ophthalmol. 2011;152(5):771–5.

    Article  PubMed  Google Scholar 

  25. Finger PT, Milman T. Microincision, aspiration cutter-assisted multifocal iris biopsy for melanoma. Eur J Ophthalmol. 2017;27(1):62–6.

    Article  PubMed  Google Scholar 

  26. Finger PT. Radiation therapy for choroidal melanoma. Surv Ophthalmol. 1997;42(3):215–32.

    Article  CAS  PubMed  Google Scholar 

  27. Petousis V, Chin KJ, Finger PT. Palladium-103 plaque radiation therapy of the anterior segment of the eye: treatment for diffuse iris melanoma. Graefes Arch Clin Exp Ophthalmol. 2011;249(6):937–40.

    Article  PubMed  Google Scholar 

  28. Finger PT. Finger’s amniotic membrane buffer technique protecting the cornea during radiation plaque therapy. Arch Ophthalmol. 2008;126(4):531–4.

    Article  PubMed  Google Scholar 

  29. Marigo FA, Finger PT. Anterior segment tumors: current concepts and innovations. Surv Ophthalmol. 2003;48(6):569–93.

    Article  PubMed  Google Scholar 

  30. Kivelä T. Alive with good vision: the ultimate goal in managing retinoblastoma. Clin Exp Ophthalmol. 2012;40(7):655–6.

    Article  PubMed  Google Scholar 

  31. Karcioglu ZA, Gordon RA, Karcioglu GL. Tumor seeding in ocular fine needle aspiration biopsy. Ophthalmology. 1985;92(12):1763–7.

    Article  CAS  Google Scholar 

  32. Manjandavida FP, Shields CL. The role of intravitreal chemotherapy for retinoblastoma. Indian J Ophthalmol. 2015;63(2):141–5.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Munier FL, Gaillard MC, Balmer A, Soliman S, Podilsky G, Moulin AP, et al. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Br J Ophthalmol. 2012;96(8):1078–83.

    Article  PubMed  Google Scholar 

  34. Smith SJ, Smith BD, Mohney BG. Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review. Br J Ophthalmol. 2014;98(3):292–7.

    Article  PubMed  Google Scholar 

  35. Reese AB, Hyman GA, Merriam GR Jr, Forrest AW, Kligerman MM. Treatment of retinoblastoma by radiation and triethylenemelamine. AMA Arch Ophthalmol. 1954;53(4):505–13.

    Article  CAS  PubMed  Google Scholar 

  36. Kiribuchi M, Hasegawa H. Retrograde infusion of anti-cancer drugs to the ophthalmic artery for intra ocular malignant tumors. Iryo. 1968;22(7):772–6.

    CAS  PubMed  Google Scholar 

  37. Abramson DH, Shields CL, Jabbour P, Teixeira LF, Fonseca J, Marques M, et al. Metastatic deaths in retinoblastoma patients treated with intraarterial chemotherapy (ophthalmic artery chemosurgery) worldwide. Int J Retina Vitreous. 2017;3:40.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Yousef YA, Soliman SE, Astudillo PP, Durairaj P, Dimaras H, Chan HS, et al. Intra-arterial chemotherapy for retinoblastoma a systematic review. JAMA Ophthalmol. 2016;134(5):584–91.

    Article  PubMed  Google Scholar 

  39. Meldrum ML, Tse DT, Benedetto P. Neoadjuvant intracarotid chemotherapy for treatment of advanced adenocystic carcinoma of the lacrimal gland. Arch Ophthalmol. 1998;116(3):315–21.

    Article  CAS  PubMed  Google Scholar 

  40. Tse DT, Kossler AL, Feuer WJ, Benedetto PW. Long-term outcomes of neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma. Ophthalmology. 2013;120(7):1313–23.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Packer S, Rotman M. Radiotherapy of choroidal melanoma with iodine-125. Ophthalmology. 1980;87(6):582–90.

    Article  CAS  PubMed  Google Scholar 

  42. The Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings COMS Report No. 18. Arch Ophthalmol. 2001;119(7):969–82.

    Article  Google Scholar 

  43. Lommatzsch PK. Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas. Twenty years’ experience. Am J Clin Oncol. 1987;10(2):146–51.

    Article  CAS  PubMed  Google Scholar 

  44. Finger PT, Chin KJ, Duvall G, Palladium-103 for Choroidal Melanoma Study Group. Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients. Ophthalmology. 2009;116(4):790–6.

    Article  Google Scholar 

  45. Finger PT. Finger’s “slotted” eye plaque for radiation therapy: treatment of juxtapapillary and circumpapillary intraocular tumors. Br J Ophthalmol. 2007;91(7):891–4.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Finger PT, Chin KJ, Tena LB. A five-year study of slotted eye plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve. Ophthalmology. 2012;119(2):415–22.

    Article  PubMed  Google Scholar 

  47. Maheshwari A, Finger PT. A 12-year study of slotted palladium-103 plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve. Am J Ophthalmol. 2018;188:60–9.

    Article  PubMed  Google Scholar 

  48. The American Brachytherapy Society - Ophthalmic Oncology Task Force. The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma. Brachytherapy. 2014;13(1):1–14.

    Article  Google Scholar 

  49. Finger PT. Radiation therapy for orbital tumors: concepts, current use and ophthalmic radiation side effects. Surv Ophthalmol. 2009;54(5):545–68.

    Article  PubMed  Google Scholar 

  50. Finger PT, Tena LB, Semenova E, Aridgides P, Choi WH. Extrascleral extension of choroidal melanoma: post-enucleation high-dose-rate interstitial brachytherapy of the orbit. Brachytherapy. 2014;13(3):275–80.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Puneet Jain .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jain, P., Finger, P.T. (2020). Newer Technologies in Ocular Oncology. In: Ichhpujani, P. (eds) Current Advances in Ophthalmic Technology. Current Practices in Ophthalmology. Springer, Singapore. https://doi.org/10.1007/978-981-13-9795-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-9795-0_6

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-9794-3

  • Online ISBN: 978-981-13-9795-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics